Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.

M. Galsky,E. Small,W. Oh,I. Chen,David C. Smith,A. Colevas,L. Martone,T. Curley,A. Delacruz,H. Scher,W. Kelly
DOI: https://doi.org/10.1016/J.UROLONC.2005.06.016
IF: 45.3
2005-03-01
Journal of Clinical Oncology
Abstract:
What problem does this paper attempt to address?